Skip to content

A research of biomarker and rating for patients in chronic urticaria

A research of biomarker and rating for patients in chronic urticaria

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DDD-17013003
Enrollment
Unknown
Registered
2017-10-16
Start date
2017-10-16
Completion date
Unknown
Last updated
2017-10-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic urticaria

Interventions

Gold Standard:Urticaria activity evaluation (UAS, Europe 2009 guide)(6 scores): 0 score: none urticaria, none pruritus
1 score: mild urticaria(<20 lesions/24hrs), mild pruritus (exist, but do not cause irritation)
2 score: medium urticaria(20-50 lesions/24hrs), medium pruritus(endurable, but do not have negative affect on lift and sleep)
of&#32
in&#32
peripheral&#32
blood&#32
and&#32
the&#32

Sponsors

Xi’an Jiaotong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 80 Years

Inclusion criteria

Inclusion criteria: Case group: 1. Age ranges from 6 to 80 years old; 2. Patients have no other disease in the near future; 3. Patients are diagnosed as chronic urticaria (The course of the disease is greater than or equal to 6 weeks); 4. Patients volunteere to participate in this project and be able to practitioners as required; 5. Patients have signed informed consent form, and be able to complete as required. Control group: 1. One case matches one control. Gender and age are the same with the matched case; 2. No history of chronic urticaria; 3. There is no history of the family of chronic urticaria; 4. No disease in the near future.

Exclusion criteria

Exclusion criteria: 1. The patients of chronic urticaria have other disease; 2. Patients have indications of acute infection; 3. Patients have been diagnosed with physical urticaria (including artificial urticaria), cholinergic urticaria or urticaria vasculitis; 4. The patients are unable to cooperation or do not adhere to treatment or are judged poor adherence; 5. Pregnant women and nursing mothers; 6. Patients are joining in other clinical trials.

Design outcomes

Primary

MeasureTime frame
Sensitivity;specificity;Positive predictive value;Negative predictive value;

Countries

China

Contacts

Public ContactLangchong He

Xi'an Jiaotong University

helc@mail.xjtu.edu.cn+86 029 82655392

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026